[1]
W. S. Mahmood, “Toll like receptor 2(TLR2) in acne vulgaris patients before and after oral isotretinion therapy”, Al-Kindy Col. Med. J, vol. 15, no. 1, pp. 110–113, Sep. 2019, doi: 10.47723/kcmj.v15i1.90.